ARCHIVES

Frederick RFP Held Up; NCI Probably Will Reject Any Further Delay

This article is from The Cancer Letter archive.

Vol. 02 No. 42 | October 15, 1976

Download PDF Visit The Full Archive

Related Articles

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

March 30, 2007

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

NCI Cooperative Group Clinical Trials Approved

June 26, 2009

Responses So Far Support Outstanding Investigator Grant; NCAB Members Object To Salary commitment

July 8, 1983

Rabson’s Group Hears Suggestions On Carcinogenesis

November 25, 1977

O’Connor Is New NS President, Curtiss Is Next

May 24, 1991